Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 25 2021

Niemann-Pick Disease

  • Overview
  • Snapshot
    • A 2-month-old boy is brought to the pediatrician by his parents due to feeding difficulties and an “enlarged” abdomen. On physical exam, there is insufficient weight gain and hepatosplenomegaly. On laboratory testing, there is a decrease in high-density lipoprotein (HDL)- cholesterol, elevated triglycerides, and an increase in LDL-cholesterol. Residual acid sphingomyelinase activity in peripheral blood leukocytes is <10% of controls.
  • Introduction
    • Clinical definition
      • a lipid storage disorder due to sphingomyelinase deficiency
    • Pathophysiology
      • pathobiology
        • sphingomyelinase deficiency results in the accumulation of sphingomyelin (a type of ceramide phospholipid), which deposits in the
          • central nervous system (NPD type A)
          • liver and spleen (NPD type A and B)
          • lung and bone marrow (NPD type B)
    • Genetics
      • inheritance pattern
        • autosomal recessive
      • mutations
        • chromosome
          • 11p
        • gene
          • SMPD1 gene
        • protein encoded for
          • sphingomyelinase
    • Associated conditions
      • medical conditions and comorbidities
        • hepatosplenomegaly (NPD type A and B)
        • neurodegenerative disease (NPD type A)
  • Epidemiology
    • Incidence
      • rare, however
        • in Niemann-Pick disease (NPD) type A, it is more common in the Ashkenazi Jewish population
    • Demographics
      • 1:1 male-to-female ratio
      • age bracket
        • dependent on type of NPD
          • type A can present as early as 3 months of age
          • type B typically occurs in early childhood
    • Location
      • neural tissue (NPD type A) and visceral organs such as
        • the spleen and liver (NPD type A and B); as well as the lung and bone marrow (NPD type B)
  • Presentation
    • Symptoms
      • failure to thrive
      • neurologic symptoms from demyelination
    • Physical exam
      • hepatosplenomegaly
      • cherry red pot on macula
    • Labs
      • residual acid sphingomyelinase activity is <10% of controls via
        • peripheral blood leukocytes or cultured skin fibroblasts
    • Histology
      • lipid-laden macrophages ("foam cells") can be found in the
        • liver, spleen, and bone marrow
  • Treatment
    • Conservative
      • supportive care
  • Complications
    • Splenic rupture
    • In patients with NPD type A, death is likely to occur by age 3
    • In patients with NPD type B, patients may survive into adulthood
  • Prognosis
    • Natural history of disease
      • NPD type A is a
        • fatal disease of infancy
      • NPD type B has a more
        • variable disease of presentation and age of onset; however,
          • patients typically present in early childhood
1 of 0
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options